Forecast & Rating3 analysts currently cover Actuate Therapeutics, of which 3 give a positive rating. The average price target is $11.68, about 1074.0% upside from the current price of $1.00. Coverage is limited, so the data is for reference only. Data as of Sep 9, 2026; this does not constitute investment advice.
Sep 9, 2026Price forecast
$11.681073.97%
Forecast & RatingStrong buy
3analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 2, 2026
Forecast met0.0%
Stock price$1.30
Avg. target$25.0
High target$35
Low target$20
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.